Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol/Acetaminophen SR vs IR in Acute Toothache
NCT01920386Phase 3Completed
- Sponsor
- Daewon Pharm
- Start
- Jun 2013
- Primary completion
- Sep 2013
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised, double-blind trial of Wontran ER (2 arms), sponsored by Daewon Pharm. Primary endpoint: Sum of the Pain Intensity Differences at 12 hours. Started Jun 2013; status: completed.
02
Drugs
Wontran ER
Beyond the preview
Go deeper on NCT01920386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01920386.